So far, well-established markers of heart failure and myocardial damage in clinical practice, such as NT-proBNP and troponin T, were used in monitoring the effects of balloon pulmonary angioplasty in patients with CTEPH [38,39]. This evidence concerns the gene NPPB and heart failure.